Literature DB >> 23135266

Evaluating Drosophila p53 as a model system for studying cancer mutations.

Gal Herzog1, Andreas C Joerger, Merav D Shmueli, Alan R Fersht, Ehud Gazit, Daniel Segal.   

Abstract

The transcription factor p53 is a key tumor suppressor protein. In about half of human cancers, p53 is inactivated directly through mutation in its sequence-specific DNA-binding domain. Drosophila p53 (Dmp53) has similar apoptotic functions as its human homolog and is therefore an attractive model system for studying cancer pathways. To probe the structure and function of Dmp53, we studied the effect of point mutations, corresponding to cancer hot spot mutations in human p53 (Hp53), on the stability and DNA binding affinity of the full-length protein. Despite low sequence conservation, the Hp53 and Dmp53 proteins had a similar melting temperature and generally showed a similar energetic and functional response to cancer-associated mutations. We also found a correlation between the thermodynamic stability of the mutant proteins and their rate of aggregation. The effects of the mutations were rationalized based on homology modeling of the Dmp53 DNA-binding domain, suggesting that the drastically different effects of a cancer mutation in the loop-sheet-helix motif (R282W in Hp53 and R268W in Dmp53) on stability and DNA binding affinity of the two proteins are related to conformational differences in the L1 loop adjacent to the mutation site. On the basis of these data, we discuss the advantages and limitations of using Dmp53 as a model system for studying p53 function and testing p53 rescue drugs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23135266      PMCID: PMC3531747          DOI: 10.1074/jbc.M112.417980

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

1.  Drosophila p53 binds a damage response element at the reaper locus.

Authors:  M H Brodsky; W Nordstrom; G Tsang; E Kwan; G M Rubin; J M Abrams
Journal:  Cell       Date:  2000-03-31       Impact factor: 41.582

Review 2.  High-throughput screening and small animal models, where are we?

Authors:  Jean Giacomotto; Laurent Ségalat
Journal:  Br J Pharmacol       Date:  2010-05       Impact factor: 8.739

3.  Thermodynamic stability of wild-type and mutant p53 core domain.

Authors:  A N Bullock; J Henckel; B S DeDecker; C M Johnson; P V Nikolova; M R Proctor; D P Lane; A R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

4.  Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database.

Authors:  Audrey Petitjean; Ewy Mathe; Shunsuke Kato; Chikashi Ishioka; Sean V Tavtigian; Pierre Hainaut; Magali Olivier
Journal:  Hum Mutat       Date:  2007-06       Impact factor: 4.878

5.  Identification and characterization of a p53 homologue in Drosophila melanogaster.

Authors:  S Jin; S Martinek; W S Joo; J R Wortman; N Mirkovic; A Sali; M D Yandell; N P Pavletich; M W Young; A J Levine
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

6.  Inactive full-length p53 mutants lacking dominant wild-type p53 inhibition highlight loss of heterozygosity as an important aspect of p53 status in human cancers.

Authors:  Lawrence R Dearth; Hua Qian; Ting Wang; Timothy E Baroni; Jue Zeng; Stephanie W Chen; Sun Young Yi; Rainer K Brachmann
Journal:  Carcinogenesis       Date:  2006-07-21       Impact factor: 4.944

7.  Semirational design of active tumor suppressor p53 DNA binding domain with enhanced stability.

Authors:  P V Nikolova; J Henckel; D P Lane; A R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

8.  Structural evolution of C-terminal domains in the p53 family.

Authors:  Horng Der Ou; Frank Löhr; Vitali Vogel; Werner Mäntele; Volker Dötsch
Journal:  EMBO J       Date:  2007-06-21       Impact factor: 11.598

9.  Crystal structure of a superstable mutant of human p53 core domain. Insights into the mechanism of rescuing oncogenic mutations.

Authors:  Andreas C Joerger; Mark D Allen; Alan R Fersht
Journal:  J Biol Chem       Date:  2003-10-08       Impact factor: 5.157

10.  Effects of common cancer mutations on stability and DNA binding of full-length p53 compared with isolated core domains.

Authors:  Hwee Ching Ang; Andreas C Joerger; Sebastian Mayer; Alan R Fersht
Journal:  J Biol Chem       Date:  2006-06-05       Impact factor: 5.157

View more
  10 in total

Review 1.  p53 in the game of transposons.

Authors:  Annika Wylie; Amanda E Jones; John M Abrams
Journal:  Bioessays       Date:  2016-09-19       Impact factor: 4.345

2.  The function of Drosophila p53 isoforms in apoptosis.

Authors:  B Zhang; M Rotelli; M Dixon; B R Calvi
Journal:  Cell Death Differ       Date:  2015-04-17       Impact factor: 15.828

Review 3.  Recent developments in the use of differential scanning fluorometry in protein and small molecule discovery and characterization.

Authors:  Anton Simeonov
Journal:  Expert Opin Drug Discov       Date:  2013-06-06       Impact factor: 6.098

4.  Computational and experimental characterization of dVHL establish a Drosophila model of VHL syndrome.

Authors:  Merav D Shmueli; Lee Schnaider; Gal Herzog; Ehud Gazit; Daniel Segal
Journal:  PLoS One       Date:  2014-10-13       Impact factor: 3.240

5.  Evolution of p53 transactivation specificity through the lens of a yeast-based functional assay.

Authors:  Mattia Lion; Ivan Raimondi; Stefano Donati; Olivier Jousson; Yari Ciribilli; Alberto Inga
Journal:  PLoS One       Date:  2015-02-10       Impact factor: 3.240

6.  Cancer associated missense mutations in BAP1 catalytic domain induce amyloidogenic aggregation: A new insight in enzymatic inactivation.

Authors:  Sushmita Bhattacharya; Pranita Hanpude; Tushar Kanti Maiti
Journal:  Sci Rep       Date:  2015-12-18       Impact factor: 4.379

Review 7.  Seeding of proteins into amyloid structures by metabolite assemblies may clarify certain unexplained epidemiological associations.

Authors:  Dorin Sade; Shira Shaham-Niv; Zohar A Arnon; Omid Tavassoly; Ehud Gazit
Journal:  Open Biol       Date:  2018-01       Impact factor: 6.411

8.  Aggregation tendencies in the p53 family are modulated by backbone hydrogen bonds.

Authors:  Elio A Cino; Iaci N Soares; Murilo M Pedrote; Guilherme A P de Oliveira; Jerson L Silva
Journal:  Sci Rep       Date:  2016-09-07       Impact factor: 4.379

9.  Evolutionary history of the p53 family DNA-binding domain: insights from an Alvinella pompejana homolog.

Authors:  Thierry Soussi; Andreas C Joerger; Qiang Zhang; Dimitrios-Ilias Balourdas; Bruno Baron; Alon Senitzki; Tali E Haran; Klas G Wiman
Journal:  Cell Death Dis       Date:  2022-03-07       Impact factor: 8.469

10.  Liquid-like droplet formation by tumor suppressor p53 induced by multivalent electrostatic interactions between two disordered domains.

Authors:  Kiyoto Kamagata; Saori Kanbayashi; Masaya Honda; Yuji Itoh; Hiroto Takahashi; Tomoshi Kameda; Fumi Nagatsugi; Satoshi Takahashi
Journal:  Sci Rep       Date:  2020-01-17       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.